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Acute respiratory illness (ARI) due to various viruses is not only the most common cause of
upper respiratory infection in humans but is also a major cause of morbidity and mortality,
leading to diseases such as bronchiolitis and pneumonia. Previous studies have shown
that respiratory syncytial virus (RSV), human rhinovirus (HRV), human metapneumovirus
(HMPV), human parainﬂuenza virus (HPIV), and human enterovirus infections may be
associated with virus-induced asthma. For example, it has been suggested that HRV
infection is detected in the acute exacerbation of asthma and infection is prolonged. Thus
it is believed that the main etiological cause of asthma is ARI viruses. Furthermore, the
number of asthma patients in most industrial countries has greatly increased, resulting
in a morbidity rate of around 10−15% of the population. However, the relationships
between viral infections, host immune response, and host factors in the pathophysiology
of asthma remain unclear. To gain a better understanding of the epidemiology of virus-
induced asthma, it is important to assess both the characteristics of the viruses and the host
defense mechanisms. Molecular epidemiology enables us to understand the pathogenesis
of microorganisms by identifying speciﬁc pathways, molecules, and genes that inﬂuence
the risk of developing a disease. However, the epidemiology of various respiratory viruses
associated with virus-induced asthma is not fully understood. Therefore, in this article,
we review molecular epidemiological studies of RSV, HRV, HPIV, and HMPV infection
associated with virus-induced asthma.
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INTRODUCTION
Acute respiratory illness (ARI) is a major cause of morbidity and
mortality worldwide (Williams et al., 2002; Sloots et al., 2008). ARI
imposes a large burden on health, particularly in children. For
community-based care, ARI has been estimated at a cost of over
US$100 per case (Ehlken et al., 2005). The disease burden for ARI
is estimated at 94,037,000 disability-adjusted life years and 3.9
million deaths (World Health Organization, 2002). Thus, ARI has
a huge impact on health and society.
Although severe lower respiratory tract infections have been
observed,ARI ismost often associatedwithmild upper respiratory
infection (URI). Most ARI cases in early childhood are conﬁrmed
as URI, leading to symptoms of the common cold with coryza and
cough. In contrast, around one-third of infants with ARI develop
lower respiratory tract symptoms such as tachypnea, wheezing,
severe cough, breathlessness, and respiratory distress (Tregoning
and Schwarze, 2010). In general, viruses are the most common
causative agents of ARI. More than 200 different types of viruses
are known to cause ARI, with respiratory syncytial virus (RSV),
human rhinovirus (HRV), human metapneumovirus (HMPV),
and human parainﬂuenza virus (HPIV) most commonly iden-
tiﬁed in ARI patients. Indeed, together with these respiratory
viruses, human enterovirus (HEV), inﬂuenza virus (InfV), human
coronavirus (HCoV), adenovirus (AdV), and human bocavirus
(HBoV) account for around 70% of ARIs detected (Kusel et al.,
2006). Respiratory viral infections can have severe adverse out-
comes in patients with established asthma and are associated with
nearly 80% of asthma exacerbation episodes (Nicholson et al.,
1993; Johnston et al., 1995;Wark et al., 2002; Heymann et al., 2004;
Grissell et al., 2005). Accumulating evidence indicates that the eti-
ology of most cases of asthma, namely virus-induced asthma,
is linked to such respiratory virus infections. In addition, RSV
and HRV are the most frequently detected pathogens and may
play an important role in viral induction and exacerbation of
asthma.
Molecular biology techniques have developed rapidly over
recent years. The application of molecular techniques to the
study of virus-induced asthma enhances epidemiologic studies by
improving our ability to classify these pathogens into meaning-
ful groups (Foxman and Riley, 2001). In this review, we focus on
molecular epidemiological studies of respiratory viruses, includ-
ing RSV, HRV, HMPV, and HPIV infections, associated with
virus-induced asthma.
VIRAL INFECTION AND ASTHMA
In infancy, illnesses such as bronchiolitis share many clinical
features with acute asthma, including wheezing, rapid breath-
ing, prolonged expiratory phase inﬂammation, and respiratory
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compromise. Respiratory viruses are detected in the majority
of asthma exacerbations in both children (80–85%) and adults
(75–80%; Johnston et al., 1995; Grissell et al., 2005). In addition,
wheezing illnesses are also closely associated with respiratory viral
infections in all age groups (Gern, 2010). Fujitsuka et al. (2011)
attempted to detect various respiratory viruses in Japanese chil-
drenwith acutewheezing using PCR technology and found viruses
in samples from 86.1% patients: RSV or HRV alone were detected
in 40.9 and 31.3% patients, respectively and both RSV and HRV
were detected in 12.2% patients. Other previous reports suggested
that theprevalenceof RSVandHRV is similar (36 and42%, respec-
tively) in children less than 2 years of age, but differs (27 and 66%)
in older children (Johnston et al., 1995; Grissell et al., 2005). In
addition, Fujitsuka et al. (2011) suggested that RSV was the dom-
inant species detected in patients with no history of wheezing
and/or asthma, while HRV was dominant in patients with such a
history. Thus, the main causative viral agent of asthma depends
on previous illness and age.
Around one-third of infants who have an acute wheezing illness
go on to develop recurrent wheezing, indicating that viral respira-
tory illnesses in early life promote asthma. Recently, the “two-hit”
hypothesis has been proposed, whereby viral infections promote
asthma mainly in predisposed children (Gern, 2010). Infants who
develop virus-induced wheezing episodes are at increased risk for
subsequent asthma, but most acute wheezing illnesses in infancy
resolve with no long-term sequelae. It has been recognized for
years that RSV infections often produce the ﬁrst episode of wheez-
ing in children who go on to develop chronic asthma (Lemanske,
2004). Indicators of heightened risk for developing asthma include
wheezing episodes caused byHRV infections and the development
of atopic features such as atopic dermatitis, allergen-speciﬁc IgE
for foods or aeroallergens (e.g., house dust, mites, or cat or dog
dander), and blood eosinophilia (Figure 1). Once asthma has
been established, HRV infections are the most common cause of
FIGURE 1 | Relationship between respiratory viral infections and
development of asthma. Host-pathogen interactions that determine the
severity of respiratory illnesses, and risk for subsequent asthma was
increased by respiratory virus infection, especially due to RSV, in infants.
Although most acute wheezing resolves within a relatively short time, a
history of wheezing and host immunological conditions (e.g., atopic
features) heightens the risk for asthma. Once asthma is established, HRV
infections are the most common causative agents of asthma in children.
acute exacerbations, especially in children. As in infancy, atopy
is an important risk factor for acute episodes of virus-induced
wheezing (Kusel et al., 2007). Many previous reports have sug-
gested that such respiratory virus infections are deeply associated
with virus-induced asthma (Kusel et al., 2007; Pierangeli et al.,
2007; Kuehni et al., 2009; Fujitsuka et al., 2011; Kato et al., 2011).
Thus, it is entirely plausible that viral infections induction and/or
exacerbation asthma in children.
MOLECULAR EPIDEMIOLOGY OF RSV
Respiratory syncytial virus of genus Pneumovirus and family
Paramyxoviridae causes ARI in children (Vardas et al., 1999; Peter
and James, 2006). RSV infection may cause major problems in
infants less than 1 year of age and can lead to life-threatening
ARIs such as bronchiolitis and bronchopneumonia (Shay et al.,
1999; Leung et al., 2005; Yorita et al., 2007). Epidemiological stud-
ies suggest that around 70% of infants have experienced an RSV
infection by the age of 1 year, and 100% by the age of 2 years;
host response to the virus varies greatly, but includes upper res-
piratory tract infections, typical bronchiolitis, and RSV-induced
wheezy bronchitis (Cane, 2001; Kuehni et al., 2009). Long-term
prospective case-control and cohort studies have also linked RSV
bronchiolitis to the development of wheezing and asthma later in
childhood (Sigurs et al., 1995, 2005, 2010; Henderson et al., 2005).
Thus, RSV infections may be associated with the initiation and/or
exacerbation of asthma.
The RSV genome encodes 11 proteins (Peter and James, 2006).
Among these, the attachment glycoprotein (G) is a major struc-
tural protein that may be associated with both infectivity and
antigenicity (Johnson et al., 1987; Rueda et al., 1991). Molecular
epidemiological studies have shown that RSV can be classiﬁed into
two phylogenetic subgroups, RSV-A and RSV-B (Mufson et al.,
1985). The strains of subgroup A can be subclassiﬁed into eight
genotypes (GA1–GA7 and SAA1), as can those of subgroup B
(BA, GB1–GB4, and SAB1–3; Parveen et al., 2006). From phy-
logenetic analysis of the G gene of RSV, Martinello et al. (2002)
showed that RSV belonging to GA3 genotype may be associated
with greater severity of illness in, for example, bronchiolitis and
pneumonia. Although GA3 genotype has been detected in the
United Kingdom, Spain, and New Zealand, it is not the most
prevalent strain (Cane et al., 1991; Garcia et al., 1997; Matheson
et al., 2006). Martinello et al. (2002) therefore suggested that the
association between greater severity of illness and GA3 genotype
may be solely due to a transient shift in genotype-speciﬁc immune
status within the community. In addition, correlations between
certain strains and/or genotypes of RSV and slight differences in
disease severity have been described previously (Hall et al., 1990;
Walsh et al., 1997). Some genotypes such as subgroupA genotypes
GA1,GA2,GA5,GA7, andNA1 and subgroup B genotype BA have
been detected throughout the world in recent years (Zlateva et al.,
2004; Parveen et al., 2006; Zhang et al., 2007;Nakamura et al., 2009;
Rebuffo-Scheer et al., 2011). Of these, NA1 is a novel genotype
known to be genetically close to GA2 genotype, while GA2 geno-
type and BA genotype are the most common genotypes of RSV
subgroups A and B around the world and have persisted for many
years (Tran et al., 2013). Furthermore, a new genotype belonging
to RSV-A, ON1, has been detected in some countries, including
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Canada, Korea, Malaysia, South Africa, and Japan (Eshaghi et al.,
2012; Lee et al., 2012; Khor et al., 2013; Tsukagoshi et al., 2013;
Valley-Omar et al., 2013). This genotype contains a unique tan-
dem repeat (72nt sequence duplication) in the C-terminal 3rd
hypervariable region of the G gene, and may be classiﬁed as a
subdivision of NA1 (Eshaghi et al., 2012). Some reports have sug-
gested that the severity of illness is not linked to subgroups or
genotypes, but is associated with the quantity of RSV in nasopha-
ryngeal aspirate (Sullender, 2000; Campanini et al., 2007). A larger
population study is needed to identify the different RSV genotypes
circulating in different areas to gain a better understanding of the
relationship between disease severity and RSV genotype.
The G protein is a major antigen of RSV and amino acid substi-
tutions may be related to changes in antigenicity. There are some
reports of amino acid substitutions, and some positively selected
sites in the C-terminal 3rd hypervariable region of the G gene
have been estimated (Botosso et al., 2009; Yoshida et al., 2012;
Kushibuchi et al., 2013). For example, Yoshida et al. (2012) esti-
mated some sites under positive selection in the region (Asn250Ser,
Met262Glu, Arg297Lys,and Arg297Glu substitutions in RSV-A
strains were estimated by the REL method, and Asn273Tyr and
Leu274Pro substitutions of RSV-A, as well as Leu237Pro substi-
tution of RSV-B, were estimated by the IFEL method). Botosso
et al. (2009) found 29 and 23 amino acid sites under putative
positive selection in RSV-A and RSV-B, respectively. In addition,
some unique positively selected sites were found in the G gene
(Kushibuchi et al., 2013). These amino acid variations at these
sites might play a key role in severe respiratory infection, such as
bronchiolitis (Goto-Sugai et al., 2010). Furthermore, the rate of
molecular evolution of the region might be high. For example,
Kushibuchi et al. (2013) estimated the evolutionary rate of RSV-A
at 3.63 × 10−3 substitutions/site/year, while that of RSV-B was
estimated at 4.56 × 10−3 substitutions/site/year. Thus, it is sug-
gested that this C-terminal 3rd hypervariable region in the G gene
of RSV-A and -B evolved rapidly (Kushibuchi et al., 2013). Based
on host immunological conditions, it is suggested that host immu-
nity such as TLR4 polymorphism is linked to symptomatic RSV
infection (Delgado et al., 2009). Thus, both the antigenicity of the
viruses and host immune conditions may play important roles in
the pathophysiology of severe respiratory infections such as bron-
chiolitis, pneumonia, and virus-induced asthma (Awomoyi et al.,
2007).
MOLECULAR EPIDEMIOLOGY OF HRV
Human rhinovirus are a group of positive-sense ssRNA viruses
belonging to genus Enterovirus in the family Picornaviridae
(Turner and Couch, 2007). Although HRVs were previously
thought to be mainly associated with the common cold caus-
ing mild respiratory symptoms, recent reports strongly suggest
that HRVs may induce and/or exacerbate asthma (virus-induced
asthma; Chung et al., 2007; Turner and Couch, 2007; Busse et al.,
2010; Gern, 2010; Khadadah et al., 2010). One report suggested
that HRV wheezing illness within the ﬁrst three years of life is
signiﬁcantly associated with the development of asthma at age
6 years (Jackson et al., 2008). Another report suggested that HRVs
are major agents in the induction of wheezing and exacerba-
tion of asthma (Khadadah et al., 2010). Thus, HRVs are being
re-evaluated as important agents of ARI in humans (Imakita et al.,
2000; Papadopoulos et al., 2002; Wos et al., 2008). The basis for
these lower respiratory symptoms has been a source of contro-
versy in terms of the mechanisms of HRV pathogenesis. There are
a variety of potential barriers toHRV infectionof the lungs, includ-
ing temperature-sensitive replication of the virus. For this reason,
it is thought that the optimum propagation temperature of HRVs
may be 32–35◦C in vitro (Papadopoulos et al., 1999; Schroth et al.,
1999). However, a recent study suggested that HRVs can propa-
gate in lower airway tissues and this may be an important factor in
the development of airway obstruction, coughing, and wheezing
that can lead to bronchiolitis and pneumonia (Mosser et al., 2005).
HRV has been concomitantly isolated with bacterial pathogens in
24–54% of children and 10–18% of adults with pneumonia (Juven
et al., 2004; Templeton et al., 2005; Jennings et al., 2008). Thus, it is
not clear whether HRV is ever the causative agent for the disease.
Human rhinovirus were previously classiﬁed into two species,
HRV species A (HRV-A) and species B (HRV-B), containing over
100 serotypes (Turner and Couch, 2007). However, a genetically
heterogeneous third species, HRV species C (HRV-C), was discov-
ered recently (Lamson et al., 2006; McErlean et al., 2007). Recent
reports suggest that HRV-A, B, and C have a unique and wide
genetic diversity (McIntyre et al., 2010; Simmonds et al., 2010;
Arakawa et al., 2012). HRV-A and -C appear to be mainly asso-
ciated with ARIs and virus-induced asthma, while HRV-B has
been detected in a relatively small number of patients with ARIs
(Linsuwanon et al., 2009; Wisdom et al., 2009; Smuts et al., 2011).
Our previous ﬁndings obtained from samples from children with
ARIs in Japan indicated that HRV-A and -C can be classiﬁed into
many clusters in the phylogenetic tree, with 30% nucleotide diver-
gence of theVP4/VP2 coding region (Mizuta et al., 2010a; Arakawa
et al., 2012; Kiyota et al., 2013). In addition, Kiyota et al. (2013)
estimated that the rate of molecular evolution of theVP4/VP2 cod-
ing regionwas rapid (3.07× 10−3 substitutions/site/year) inHRV-
C. These results suggest that HRV-A and -C detected in ARI cases
are the predominant strains and have varied genetic properties
(Wisdom et al., 2009; Mizuta et al., 2010a; Arakawa et al., 2012).
Thus, the association between HRV type and disease severity is
not fully understood. There may be important differences in the
susceptibility of individuals to the replication of HRV in lower
airway tissues.
Parry et al. (2000) and Gern et al. (2000) found that weak
peripheral bloodmononuclear cell (PBMC)Th1 (IFN-γ) response
to HRV infection is associated with increased viral shedding,
and decreased proliferative response of PBMCs to HRV is asso-
ciated with increased severity of symptoms. In addition, it was
found that weak Th1 responses (IFN-γ/IL-5 mRNA ratio) in spu-
tum are also associated with greater severity of illness (Gern
et al., 2000). Furthermore, weak Th1 responses to viral infec-
tion in adults with asthma have been associated with decreased
lung function and greater airway responsiveness (Brooks et al.,
2003). These results indicate that individuals with a weak Th1
response to viruses, and perhaps individuals with asthma in gen-
eral,may bemore susceptible toHRV illnesses, and this association
may be strongest in those with more severe disease (Parry et al.,
2000; Gern et al., 2000; Brooks et al., 2003). Other epidemio-
logical and biological factors, such as allergy, atopic dermatitis,
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or a family history of allergy, may be related to virus-induced
asthma (Green et al., 2002; Singh et al., 2007). Recently it is
suggested that variants at the 17q21 locus were associated with
HRV induced asthma in children who had a history wheezing ill-
nesses, although associations of 17q21 variants with asthma were
restricted to children who had a history of HRV wheezing illnesses
(Calıs¸kan et al., 2013).
MOLECULAR EPIDEMIOLOGY OF HMPV
Human metapneumovirus is a recently identiﬁed RNA virus
belonging to the Paramyxoviridae family, of genus Metapneu-
movirus (Collins and Crowe, 2007). HMPV is a major pathogen
that causes ARI in all ages (Collins and Crowe, 2007). The
ﬁrst HMPV infection appears to take place within the ﬁrst six
months of life, after which infections may occur repeatedly and
frequently (Schildgen et al., 2011). The nosocomial impact of
HMPV is estimated to be as high as that for RSV. In an HMPV
outbreak in Japan, 34.8% of elderly patients who shared the
same day care room in a hospital were infected with HMPV
(Honda et al., 2006). Higher morbidity is observed in young
children, the elderly, and immunocompromised adults (Boivin
et al., 2002; Falsey et al., 2003; van den Hoogen et al., 2003; Sum-
ino et al., 2005; Williams et al., 2005; O’Gorman et al., 2006).
HMPV is classiﬁed into two genotypes (A and B) and four sub-
groups (A1, A2, B1, and B2) by phylogenetic analysis, using the
F and G genes (Biacchesi et al., 2003; van den Hoogen et al.,
2004). Subgroup A2 has been subdivided into two lineages, sub-
group A2a and A2b (Huck et al., 2006). It has been suggested
that these genotypes circulate in variable proportions in some
areas (Gerna et al., 2005; Mackay et al., 2006). Although the
molecular epidemiological information on HMPV has gradually
accumulated, the detailed epidemiology remains unclear (Mizuta
et al., 2010b; Pitoiset et al., 2010; Omura et al., 2011). HMPV
infections can occur throughout the year, but seasonality has
been described in several studies, with the epidemiological peak
occurring several months later than that observed for RSV epi-
demics (Robinson et al., 2005; Wilkesmann et al., 2006; Madhi
et al., 2007; Aberle et al., 2008, 2010; Heininger et al., 2009). It
remains unclear whether different HMPV subgroups are asso-
ciated with differences in the clinical course of disease. Several
groups have suggested that HMPV subgroup A might be asso-
ciated with more severe clinical disease (Martinello et al., 2002;
Kaida et al., 2006; Vicente et al., 2006; Arnott et al., 2013), while
others have reported that subgroup B may cause more severe ill-
ness (Esper et al., 2004; Pitoiset et al., 2010), and still other groups
have found no evidence for differential severity caused by dif-
ferent HMPV lineages (Agapov et al., 2006; Manoha et al., 2007;
Larcher et al., 2008; Xiao et al., 2010). Previous reports suggested
that the substitution rates for the G gene (3.5 × 10−3 substi-
tution/site/year) and the F gene (7.1 × 10−4 to 8.5 × 10−4
substitution/site/year) are high, and some positively selected sites
have been found in the latter (de Graaf et al., 2008; Yang et al.,
2009). It may be that there is a correlation between some posi-
tively selected epitopes and disease severity. Thus, the association
between HMPV subgroup and disease severity is controversial. To
gain a better understanding of host responses that may contribute
to differences in clinical severity between HMPV subgroups, a
more detailed analysis that includes host immunological status is
needed.
MOLECULAR EPIDEMIOLOGY OF HPIV
Human parainﬂuenza virus belong to the Paramyxoviridae family.
There are two genera of HPIV, Respirovirus (HPIV-1 and HPIV-3)
and Rubulavirus (HPIV-2 and HPIV-4; Karron and Collins, 2007).
HPIV is classiﬁed into four serotypes (HPIV1–4), all of which
can cause various ARI in humans such as URI, croup, bronchitis,
asthma, and pneumonia (Henrickson, 2003; Karron and Collins,
2007). AlthoughHPIV type 4 (HPIV4) is rarely reported,HPIV1-3
are important causes of various ARI, including the common cold,
croup, bronchitis, bronchiolitis, and pneumonia in children, and
they commonly re-infect both children and adults. While such
infections are generally mild in healthy persons, they may cause
serious diseases in children, such as asthma (Henrickson, 2003;
Karron and Collins, 2007). Although fewer HPIV strains have
been detected compared with other respiratory viruses such as
RSV,HRV, and HMPV, previous reports suggest that HPIV1 and 3
are the dominant viruses in children with ARI (Reed et al., 1997).
Indeed, serological surveys indicate that at least 60% of children
have been infected with HPIV3 by 2 years of age, approximately
80% have been infected by age 4, and at least 75% have been
infected with HPIV1 by 5 years of age (Parrott et al., 1959, 1962).
HPIV1 and 3 show high prevalence and are associated with up to
12% of acute lower respiratory tract infections in adults (Azevedo
et al., 2003; Matsuse et al., 2005). HPIV1 andHPIV3,may bemajor
agents of ARI throughout the world, along with other viruses such
as RSV, HRV, and HMPV (Laurichesse et al., 1999; Iwane et al.,
2004; Monto, 2004; Do et al., 2011). In addition, it is suggested
that HPIV is a major causative agent of virus-induced asthma
(Henrickson and Savatski, 1997). Several previous studies have
reported that HPIV1 infections demonstrate clear outbreaks in
autumn,mostly in September and November, every 2 years (Knott
et al., 1994; Hall, 2001; Counihan et al., 2001). Other studies have
reported that HPIV3 causes yearly outbreaks around the globe,
mainly in the spring-summer season (Knott et al., 1994; Couni-
han et al., 2001; Hall, 2001; Mizuta et al., 2013). A recent study
suggested that four different types of HPIV cause similar clinical
manifestations in patients, and the clinical presentation of HPIV
infection may differ depending on patient age (Liu et al., 2013).
Henrickson and Savatski (1996) analyzed the longitudinal evo-
lution of the HN coding region in 13 strains of HPIV1 isolated in
the USA. These results showed that the antigenic and genetic sub-
groups are very stable. In addition, Mizuta et al. (2011) suggested
that the evolution of the HN gene in the present HPIV1 isolates
was relatively slow and that the gene is highly conserved. Only a
few reports on the molecular epidemiology of HPIV1 are available
and it appears that the molecular epidemiology of HPIV is poorly
understood. Larger and more detailed studies on the association
of HPIV with asthma are needed.
MOLECULAR EPIDEMIOLOGY OF OTHER VIRUSES
HEV68 was recently detected in asthmatic patients (Hasegawa
et al., 2011). HEV68 was found to be relatively acid resistant and
thus could be distinguished from acid-sensitive HRV87 (Schieble
et al., 1967; Kapikian et al., 1971). HRV87 was recently reclassiﬁed
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as HEV68 based on phylogenetic analysis and neutralization
test, and some laboratories have conﬁrmed its acid sensitivity
(Blomqvist et al., 2002; Ishiko et al., 2002; Savolainen et al., 2002).
Distinguishing between HRV and HEV based on the acid sensitiv-
ity of isolates is therefore not appropriate for HEV68. The number
of reports of an association between respiratory disease and
HEV68 infection has recently increased. One report of the phy-
logenetic analysis of HEV68 based on partial VP1 gene sequences
indicates wide genetic diversity (Linsuwanon et al., 2012). In addi-
tion, Tokarz et al. (2012) showed the presence of multiple clades
among the circulating strains, and that all strains are spreading
rapidly worldwide and contributing to the prevalence rates of res-
piratory diseases. In addition, asthmatic individuals infected with
HEV68 also have the propensity to develop unstable asthma or an
acute attack (Hasegawa et al., 2011).
Inﬂuenza virus is also a major causative agent of ARI in both
children and adults. Furthermore, asthmatic patients were found
among children and adults hospitalized with seasonal InfV (Dao
et al., 2010; Dawood et al., 2010). Although it is recognized that
viral infections such as RSV or HRV may induce and/or exacerbate
asthma, the effect of InfV on asthma remains arguable (Johnston
et al., 1995). Although one study suggested that A(H1N1)pdm09
viruses impose greater risk factors on children than seasonal InfV
(Tran et al., 2012), InfV vaccine was available before the inﬂuenza
season since InfV causes more severe illness than other respi-
ratory viruses. Therefore, it is suggested that InfV vaccine be
recommended for children with asthma (Kloepfer et al., 2012).
Although the level of detection of HCoV,HBoV, or AdV is rela-
tively low, these infections are also detected in children with acute
wheezing (Chung et al., 2007; Jartti et al., 2007). Further studies
are needed to clarify the clinical roles of HCoV, HBoV, or AdV
infections and those of other respiratory viruses. In particular, the
prevalence of HCoV, HBoV, or AdV infection in healthy control
subjects, assessment of disease severity by other clinical variables,
and the immunological effects should be investigated.
MOLECULAR EPIDEMIOLOGY OF CO-INFECTION
Infants with severe bronchiolitis have an increased risk of devel-
oping recurrent wheezing later in life (Chung et al., 2007). HRV
may be detected concurrently with other viruses such as RSV,
HMPV, InfV, or HCoV (Richard et al., 2008; Fujitsuka et al., 2011).
Considering their ubiquity, it is interesting that the number of
respiratory viruses detected concurrently with HRV strains is rel-
atively low (Lambert et al., 2007; Mackay, 2007), supporting the
concept that HRVs have a direct role in the clinical outcome of
infection (Miller et al., 2007). In fact, HRV strains are co-detected
with other pathogens in reproducible, but clinically undeﬁned,
patterns (Brunstein et al., 2008). The HRV partnership with host
immunity may be a mutualistic one, inadvertently imparting an
advantage to the host by protecting against more cytopathic res-
piratory viral pathogens while the host provides a vessel for HRV
replication and transmission.
Respiratory viruses other than RSV and multiple viral infec-
tions may contribute to the severity of bronchiolitis and asthma.
Indeed, it was reported that dual infections of HMPV and RSV or
HRV and RSV confer a 5- to 10-fold increase of severe disease in
children admitted to pediatric intensive care units (Papadopou-
los et al., 2002; Semple et al., 2005). In contrast, other studies
reported that co-infection with two respiratory viruses was not
signiﬁcantly associated with disease severity (van Woensel et al.,
2006; Wolf et al., 2006). Thus, there is no consensus on the effects
of co-infection on disease severity. The effect of dual infection
may depend upon which viruses co-infect together. For exam-
ple, although there was no increase in severity when HRV and/or
AdV were detected during RSV infection, co-infection with both
HMPV and RSV increased the rate of intensive care unit admis-
sions (Aberle et al., 2005; Semple et al., 2005). Thus, although dual
infections and reinfections have beenwell documented in children,
chronic infection with the development of quasispecies cannot
be ruled out without obtaining more complete data using high
performance detection methods (Hall and McCarthy, 1996).
CONCLUSION
Respiratory viral infections are a major cause of virus-induced
asthma in early life. Although antiviral therapy is not yet avail-
able for patients infected with respiratory viruses, the detection
and identiﬁcation of these viruses could help to explain serious
respiratory illness, provide guidance for medical care, and prevent
unnecessary treatment with antibiotics. Based on the results of
many related studies, we propose a two-step hypothesis of asthma
development in children. The ﬁrst step is mainly due to RSV
infection: when RSV infects bronchial cells, the bronchial cells
produce various cytokines and chemokines. These responses cause
hyperresponsiveness in the bronchial cells. In other words, RSV
infection might create a preparatory step as the ﬁrst step in the
development of asthma. HRV infection might then bring about
the second step in the development of asthma. An infant with
a history of wheezing caused by RSV infection may develop the
heavy wheezing of asthma due to HRV infection followed by RSV
infection. To understand the cause of asthma, we need to examine
the larger complex picture of genetic susceptibility, immune com-
ponents, environmental exposures, and the interactions between
these elements.
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